AKEBIA THERAPEUTICS INC's ticker is AKBA and the CUSIP is 00972D105. A total of 121 filers reported holding AKEBIA THERAPEUTICS INC in Q1 2024. The put-call ratio across all filers is 0.79 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $1,010 | -26.2% | 748 | 0.0% | 0.00% | – |
Q1 2024 | $1,369 | +47.5% | 748 | 0.0% | 0.00% | – |
Q4 2023 | $928 | +8.8% | 748 | 0.0% | 0.00% | – |
Q3 2023 | $853 | +24.5% | 748 | 0.0% | 0.00% | – |
Q2 2023 | $685 | +63.1% | 748 | 0.0% | 0.00% | – |
Q1 2023 | $420 | -2.8% | 748 | 0.0% | 0.00% | – |
Q4 2022 | $432 | -78.4% | 748 | 0.0% | 0.00% | – |
Q4 2020 | $2,000 | 0.0% | 748 | 0.0% | 0.00% | – |
Q3 2020 | $2,000 | -80.0% | 748 | 0.0% | 0.00% | – |
Q2 2020 | $10,000 | +66.7% | 748 | 0.0% | 0.00% | – |
Q1 2020 | $6,000 | +20.0% | 748 | 0.0% | 0.00% | – |
Q4 2019 | $5,000 | +66.7% | 748 | 0.0% | 0.00% | – |
Q3 2019 | $3,000 | -25.0% | 748 | 0.0% | 0.00% | – |
Q2 2019 | $4,000 | -33.3% | 748 | 0.0% | 0.00% | – |
Q1 2019 | $6,000 | +50.0% | 748 | 0.0% | 0.00% | – |
Q4 2018 | $4,000 | – | 748 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Alerce Investment Management, L.P. | 4,652,561 | $13,027,000 | 5.13% |
Orchard Capital Management, LLC | 857,138 | $2,400,000 | 1.02% |
Nantahala Capital Management | 7,040,487 | $19,713,000 | 0.61% |
OCCUDO QUANTITATIVE STRATEGIES LP | 209,040 | $585,000 | 0.18% |
Woodline Partners LP | 2,382,522 | $6,671,000 | 0.18% |
RICE HALL JAMES & ASSOCIATES, LLC | 1,546,169 | $4,329,000 | 0.15% |
Virtus ETF Advisers LLC | 92,771 | $260,000 | 0.11% |
Jump Financial, LLC | 155,583 | $435,000 | 0.07% |
GSA CAPITAL PARTNERS LLP | 128,626 | $360,000 | 0.06% |
Anson Funds Management LP | 95,342 | $267,000 | 0.05% |